Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

Clinical trial NCT02330562 · COMPLETED

Trial details

NCT number: NCT02330562
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma

Start date: 2015-04-15
Primary completion: 2021-06-02
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.